東方雨虹(002271.SZ):擬6億元投建南寧綠色新材料生產基地項目
格隆匯3月18日丨東方雨虹(002271.SZ)公佈,2022年3月18日,公司與南寧市興寧區人民政府簽訂《項目投資協議書》,協議約定公司擬投資6億元在廣西南寧市興寧區投資建設東方雨虹南寧綠色新材料生產基地項目,建設內容為推進包括但不限於防水、節能保温材料、民用建築材料、建築塗料等的產品研發生產項目。
該項目分兩期建設,一期項目預計投資6億元,計劃在取得《國有土地使用權掛牌出讓成交確認書》後10個月內辦理完畢施工許可證,取得施工許可證之日起1個月內開工建設,開工之日起24個月內陸續投產;二期項目由雙方另行約定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.